See more : Tupperware Brands Corporation (TUP) Income Statement Analysis – Financial Results
Complete financial analysis of Aleafia Health Inc. (ALEAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aleafia Health Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- The Charles Schwab Corporation (SCHW) Income Statement Analysis – Financial Results
- Yippy, Inc. (YIPI) Income Statement Analysis – Financial Results
- Keli Sensing Technology (Ningbo) Co.,Ltd. (603662.SS) Income Statement Analysis – Financial Results
- KKR Real Estate Finance Trust Inc. (KREF) Income Statement Analysis – Financial Results
- Red Trail Energy, LLC (REGX) Income Statement Analysis – Financial Results
Aleafia Health Inc. (ALEAF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.aleafiahealth.com
About Aleafia Health Inc.
Aleafia Health Inc. operates as a cannabis health and wellness products and services company in Canada and internationally. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates. In addition, the company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners; and operates education centers. It offers its products under the Divvy, Sunday Market, Bogart's Kitchen, Noon & Night, Nith & Grand, Kin Slips, and Emblem brands. The company is headquartered in Concord, Canada.
Metric | 2022 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 42.85M | 44.54M | 16.35M | 3.33M | 15.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 36.85M | 50.15M | -4.43M | 541.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 6.00M | -5.61M | 20.78M | 2.79M | 15.77K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 14.00% | -12.59% | 127.10% | 83.73% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 17.70M | 31.94M | 38.85M | 20.01M | 9.53M | 65.10K | 130.05K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 0.00 | 0.00 |
Selling & Marketing | 2.46M | 0.00 | 0.00 | 933.43K | 114.01K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 20.17M | 31.94M | 38.85M | 20.94M | 9.65M | 65.10K | 130.05K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
Other Expenses | 3.37M | 8.06M | 5.91M | 1.66M | 60.46K | 52.98K | 16.63K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 23.54M | 40.00M | 44.77M | 22.60M | 9.71M | 65.10K | 146.68K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
Cost & Expenses | 60.39M | 90.15M | 40.33M | 23.14M | 9.71M | 65.10K | 146.68K | 178.28K | 515.61K | 2.57M | 484.84K | 86.27K | 160.45K | 87.16K |
Interest Income | 0.00 | 0.00 | 417.00K | 169.84K | 0.00 | 0.00 | 0.00 | 61.00 | 169.00 | 4.14K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 9.36M | 403.53M | 6.38M | 0.00 | 0.00 | 2.42K | 1.40K | 0.00 | 1.71K | 0.00 | 14.70K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 6.57M | 10.16M | 6.63M | 1.56M | 60.46K | 0.00 | 0.00 | 61.00 | 169.00 | 4.14K | -70.00K | 0.00 | 951.64K | 0.00 |
EBITDA | -10.97M | 163.92M | -17.35M | -18.25M | -9.63M | -12.12K | -146.68K | -178.22K | -515.44K | -2.57M | -554.84K | -86.27K | 791.19K | -87.16K |
EBITDA Ratio | -25.61% | 368.01% | -106.12% | -548.10% | -61,089.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -17.54M | 153.75M | -23.98M | -19.81M | -9.69M | -12.12K | -146.68K | -178.28K | -515.61K | -2.57M | -484.84K | -86.27K | -160.45K | -87.16K |
Operating Income Ratio | -40.93% | 345.19% | -146.68% | -594.92% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -17.07M | -403.53M | -12.67M | 269.84K | 0.00 | 2.13K | -1.40K | -2.97M | 7.54K | 8.31K | 57.00K | 0.00 | -951.64K | 0.00 |
Income Before Tax | -34.61M | -249.78M | -36.65M | -19.54M | -9.69M | -9.98K | -148.08K | -3.14M | -509.62K | -2.56M | -512.55K | -86.27K | -1.11M | -87.16K |
Income Before Tax Ratio | -80.77% | -560.77% | -224.13% | -586.81% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 7.71M | -2.54M | 2.96M | -1.01M | 0.00 | -4.55K | 0.00 | 2.97M | -7.71K | -12.45K | -10.31K | 0.00 | 951.64K | 0.00 |
Net Income | -42.32M | -247.24M | -39.61M | -18.53M | -9.69M | -5.44K | -148.08K | -3.14M | -509.62K | -2.56M | -502.24K | -86.27K | -1.11M | -87.16K |
Net Income Ratio | -98.77% | -555.07% | -242.23% | -556.55% | -61,473.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.11 | -0.85 | -0.18 | -0.16 | -0.24 | -0.01 | -0.15 | -3.15 | -0.57 | -3.50 | -1.17 | -0.20 | -14.51 | -0.20 |
EPS Diluted | -0.11 | -0.85 | -0.18 | -0.16 | -0.24 | -0.01 | -0.15 | -3.15 | -0.57 | -3.50 | -1.17 | -0.20 | -14.51 | -0.20 |
Weighted Avg Shares Out | 386.36M | 291.59M | 215.62M | 117.16M | 39.98M | 998.95K | 998.95K | 998.95K | 898.88K | 730.95K | 430.20K | 430.20K | 76.63K | 430.20K |
Weighted Avg Shares Out (Dil) | 386.36M | 291.59M | 215.62M | 117.16M | 39.98M | 998.95K | 998.95K | 998.95K | 898.88K | 730.95K | 430.20K | 430.20K | 76.63K | 430.20K |
7 Medical Marijuana Stocks for a Healthcare Revolution
Aleafia Health Launches High Potency CBD 50 Cannabis Oil
Aleafia Health Inc. (ALEAF) CEO Geoffrey Benic on Q3 2020 Results - Earnings Call Transcript
Aleafia Health Announces Third Quarter 2020 Results
Aleafia Health Successful Outdoor Harvest Accelerates Product Portfolio Expansion
Source: https://incomestatements.info
Category: Stock Reports